Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 6, 2000

View Archived Issues

Tibolone improves auditory function in postmenopausal women

FDA informs Urologix of new developments concerning the Targis System

Apo A-IV peptide suppresses appetite in obese rats, offered for licensing

AstraZeneca explores novel strategy for treating diabetes and certain other disorders

NPY receptor antagonists with dihydropyridine structure disclosed by Bristol-Myers Squibb

Atridox periodontal therapy approved in E.U.

New series of NOS inhibitors in early development at Pfizer

Imidazole cytokine inhibitors in the pipeline at SmithKline Beecham

Zambon and Sheffield begin clinical program for MSI-ipratropium

New thrombin inhibitors presented by Merck & Co. research group

Orally active, selective iNOS inhibitors discovered at Glaxo Wellcome

Protein-tyrosine-phosphatases explored at AHP as novel target for diabetes Rx

New developments announced for AltaRex's ovarian cancer therapy

Glaxo discovers PPARgamma agonist with excellent pharmacological and pharmacokinetic profile

Medarex antibody therapy reduces inflammation in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...